Clinical research

Early and late results of percutaneous revascularization in patients with ischemic cardiomyopathy and decreased left ventricular ejection fraction.

EuroIntervention 2005;1:186-192 - DOI10.4244/EIJV1I2A30.

Pawel Buszman
Pawel Buszman1*, MD, FACC, FSCAI; Iwona Szkróbka, MD1; Zofia Tendera, MD1; Agata Gruszka1, MD; Bozena Bialkowska1, MD; Radoslaw Parma1, MD; Wojciech Wojakowski1, MD; Marek Król1; Stefan R. Kiesz3, MD, FACC; Andrzej Bochenek2, MD; Michal Tendera1, MD, FESC, FACC
1. 3rd Division of Cardiology and Acute Coronary Care Unit, Silesian School of Medicine, Katowice, Poland; 2. 1st Division of Cardiac Surgery, Silesian School of Medicine, Katowice, Poland; 3. American Heart of Poland, Ustron, Poland

Aims: REvascularization in Ischaemic HEart Failure Trial (REHEAT) is a registry prospectively evaluating the outcomes of percutaneous myocardial revascularization in postinfarction patients

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

percutaneous coronary intervention (pci)coronary artery bypass grafting (cabg)heart failure
Read next article
Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stent

Latest news